Cargando…

Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome

Antiphospholipid syndrome (APS) is a chronic and disabling condition characterized by recurrent thrombosis and miscarriages mediated by antibodies against phospholipid-binding proteins (aPL), such as beta(2)glycoprotein I (β(2)GPI). Complement is involved in APS animal models and complement deposits...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lonati, Paola Adele, Scavone, Mariangela, Gerosa, Maria, Borghi, Maria Orietta, Pregnolato, Francesca, Curreli, Daniele, Podda, Gianmarco, Femia, Eti Alessandra, Barcellini, Wilma, Cattaneo, Marco, Tedesco, Francesco, Meroni, Pier Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474283/ https://www.ncbi.nlm.nih.gov/pubmed/31031764 http://dx.doi.org/10.3389/fimmu.2019.00773

Ejemplares similares

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
por: Tedesco, Francesco, et al.
Publicado: (2018)

Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccination
por: Lonati, Paola Adele, et al.
Publicado: (2022)

Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients.
por: Meroni, Pier Luigi, et al.
Publicado: (2023)

New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats
por: Durigutto, Paolo, et al.
Publicado: (2019)

Antiphospholipid Antibody Assays in 2021: Looking for a Predictive Value in Addition to a Diagnostic One
por: Meroni, Pier Luigi, et al.
Publicado: (2021)

In-vitro and in-vivo metabolism of different aspirin formulations studied by a validated liquid chromatography tandem mass spectrometry method
por: Dei Cas, Michele, et al.
Publicado: (2021)

The Complement System in the Pathophysiology of Pregnancy and in Systemic Autoimmune Rheumatic Diseases During Pregnancy
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2020)

Platelet Adhesion and Thrombus Formation in Microchannels: The Effect of Assay-Dependent Variables
por: Scavone, Mariangela, et al.
Publicado: (2020)

Antiglutamate Receptor Antibodies and Cognitive Impairment in Primary Antiphospholipid Syndrome and Systemic Lupus Erythematosus
por: Gerosa, Maria, et al.
Publicado: (2016)

β2 glycoprotein I participates in phagocytosis of apoptotic neurons and in vascular injury in experimental brain stroke
por: Grossi, Claudia, et al.
Publicado: (2021)

Anti-Phospholipid Antibodies and Coronavirus Disease 2019: Vaccination Does Not Trigger Early Autoantibody Production in Healthcare Workers
por: Borghi, Maria Orietta, et al.
Publicado: (2022)

Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriers
por: Roggenbuck, Dirk, et al.
Publicado: (2016)

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
por: Pericleous, Charis, et al.
Publicado: (2016)

Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome
por: Raimondo, Maria Gabriella, et al.
Publicado: (2017)

Scleroderma-specific autoantibodies embedded in immune complexes mediate endothelial damage: an early event in the pathogenesis of systemic sclerosis
por: Raschi, Elena, et al.
Publicado: (2020)

Complement in the Pathophysiology of the Antiphospholipid Syndrome
por: Chaturvedi, Shruti, et al.
Publicado: (2019)

Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome
por: Naranjo, Laura, et al.
Publicado: (2022)

Complement activation and endothelial perturbation parallel COVID-19 severity and activity
por: Cugno, Massimo, et al.
Publicado: (2021)

Beyond Systemic Lupus Erythematosus and Anti-Phospholipid Syndrome: The Relevance of Complement From Pathogenesis to Pregnancy Outcome in Other Systemic Rheumatologic Diseases
por: Cavalli, Silvia, et al.
Publicado: (2022)

Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies
por: Nalli, Cecilia, et al.
Publicado: (2021)

Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers
por: Meroni, Pier Luigi, et al.
Publicado: (2014)

Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Devreese, Katrien M.J., et al.
Publicado: (2021)

The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
por: Erkan, Doruk, et al.
Publicado: (2016)

Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome
por: Ripoll, Vera M., et al.
Publicado: (2018)

Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome
por: Borghi, Maria Orietta, et al.
Publicado: (2020)

Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
por: Barratt-Due, Andreas, et al.
Publicado: (2016)

Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
por: Savelli, Stephanie L., et al.
Publicado: (2019)

Effectiveness and Tolerability of Repeated Courses of Viscosupplementation in Symptomatic Hip Osteoarthritis: A Retrospective Observational Cohort Study of High Molecular Weight vs. Medium Molecular Weight Hyaluronic Acid vs. No Viscosupplementation
por: De Lucia, Orazio, et al.
Publicado: (2019)

Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
por: Holers, V. Michael, et al.
Publicado: (2002)

THE LOCALIZATION OF IN VIVO BOUND COMPLEMENT IN TISSUE SECTIONS
por: Lachmann, P. J., et al.
Publicado: (1962)

BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS
por: Ward, Peter A., et al.
Publicado: (1965)

Cell-bound complement activation products in SLE
por: Ramsey-Goldman, Rosalind, et al.
Publicado: (2017)

Purified IgG from Patients with Obstetric but not IgG from Non-obstetric Antiphospholipid Syndrome Inhibit Trophoblast Invasion
por: Poulton, Katie, et al.
Publicado: (2015)

Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Meroni, Pier Luigi, et al.
Publicado: (2019)

Platelets and the Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus or Antiphospholipid Syndrome
por: Vils, Signe Risbøl, et al.
Publicado: (2023)

Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations
por: Meroni, Pier Luigi, et al.
Publicado: (2014)

Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdOx1 nCov-19 vaccine
por: Scavone, Mariangela, et al.
Publicado: (2021)

Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome
por: Benagiano, Marisa, et al.
Publicado: (2019)

Is It Antiphospholipid Syndrome?
por: Ditto, Maria Chiara, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_agdjup1n6p2u8hu72a426nifbo